1. Home
  2. LMB vs IVA Comparison

LMB vs IVA Comparison

Compare LMB & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$79.56

Market Cap

960.5M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.02

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
IVA
Founded
1901
2011
Country
United States
France
Employees
1400
77
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.5M
883.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
LMB
IVA
Price
$79.56
$4.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$116.67
$16.20
AVG Volume (30 Days)
323.5K
466.4K
Earning Date
05-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
N/A
EPS
0.36
N/A
Revenue
$646,804,000.00
N/A
Revenue This Year
$15.96
N/A
Revenue Next Year
$5.90
$751.20
P/E Ratio
$234.25
N/A
Revenue Growth
24.68
N/A
52 Week Low
$65.08
$2.94
52 Week High
$154.04
$7.98

Technical Indicators

Market Signals
Indicator
LMB
IVA
Relative Strength Index (RSI) 49.10 32.13
Support Level $76.97 $3.77
Resistance Level $85.38 $4.67
Average True Range (ATR) 4.91 0.32
MACD 1.16 -0.12
Stochastic Oscillator 63.27 12.35

Price Performance

Historical Comparison
LMB
IVA

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: